The theme for this session will be “Decision making and personalized medicine”. For a drug developer a decision can be to stop or continue development, which dose to select or which patient subgroup to target. For an individual a decision on treatment choice has to be made.
We have two speakers for this session and welcome more on any topic related to decision making and/or personalized medicine.
Speakers will have 20-30 minutes to present followed by roughly 10 minutes of Q&A at the end of their presentation. Please consider volunteering to present and let the committee know by 2 May latest.
We look forward to hearing from you and to meeting again soon!